![Gad Berdugo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gad Berdugo
Presidente presso
GENFLOW BIOSCIENCES PLC
Profilo
Gad Berdugo was the founder of Explorium Capital LLC, founded in 2008, serving as Managing Partner from 2008 to 2012.
Mr. Berdugo was the founder of Epivax Oncology, Inc., founded in 2017, serving as Chief Executive Officer & Director.
Mr. Berdugo currently serves as Independent Non-Executive Chairman at Genflow Biosciences Plc starting in 2026.
Former jobs include Director-Global Business Development at Baxter Healthcare Corp., Director at MabCure, Inc. from 2010 to 2011, Independent Director at EVEXTA BIO SA, Managing Director & Head-Life Sciences at Tegris Corp., Director at Genome Profiling LLC, Chief Business Officer at Nutcracker Therapeutics, Inc., Equity Analyst at Lazard Asset Management LLC, CFO, Secretary & Executive VP-Administration at Immune Pharmaceuticals, Inc. in 2015, and Chief Business Officer at Editas Medicine, Inc. from 2020 to 2021.
Education includes undergraduate studies at Imperial College London, graduate studies at University College London, and an MBA from École des Hautes Études Commerciales de Paris.
Posizioni attive di Gad Berdugo
| Società | Posizione | Inizio |
|---|---|---|
| GENFLOW BIOSCIENCES PLC | Presidente | 19/01/2026 |
Precedenti posizioni note di Gad Berdugo
| Società | Posizione | Fine |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 26/07/2021 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Develops mutanome-directed, neo-epitope personalized therapeutic vaccines | Fondatore | 01/06/2020 |
| IMMUNE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 31/12/2015 |
Explorium Capital LLC
 Explorium Capital LLC Investment ManagersFinance Explorium Capital focuses on equity investments mainly in free cash flow generating, publicly-traded global healthcare and life sciences companies. | Fondatore | 01/01/2012 |
| MABCURE INC | Direttore/Membro del Consiglio | 02/06/2011 |
Formazione di Gad Berdugo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
32
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
MabCure, Inc.
 MabCure, Inc. Pharmaceuticals: MajorHealth Technology Develops novel diagnostics | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lazard Asset Management LLC
 Lazard Asset Management LLC Investment ManagersFinance LAM offers products across a broad spectrum of asset classes, designed for different client types. The firm’s traditional and alternative investment services cover listed equity and fixed income investments in a wide range of global, regional and country specific strategies. Risk management is integral to their portfolio construction. They rely heavily on fundamental, bottom-up investment research. | Finance |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tegris Corp. | |
Explorium Capital LLC
Explorium Capital LLC Investment ManagersFinance Explorium Capital focuses on equity investments mainly in free cash flow generating, publicly-traded global healthcare and life sciences companies. | Finance |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Engages in the research of diagnostic products | Health Technology |
Genome Profiling LLC
 Genome Profiling LLC Packaged SoftwareTechnology Services Provides software platform to to discover novel epigenetic biomarkers that scientists and medical professionals | Technology Services |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Develops mutanome-directed, neo-epitope personalized therapeutic vaccines | Health Technology |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops an end-to-end RNA therapeutics platform that integrates AI-driven RNA design, lipid nanoparticle delivery solutions | Commercial Services |
Genflow Biosciences Plc
 Genflow Biosciences Plc BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
